Exercise May Help Mitigate Cognitive Decline During Chemotherapy

A recent Phase II clinical trial published in the journal CANCER suggests that simple, home-based exercise routines may significantly alleviate the cognitive impairment often referred to as "chemo brain." Affecting up to 80% of chemotherapy patients, this condition manifests as memory lapses, difficulty concentrating, and challenges with multitasking, which can severely impact a patient's quality of life during treatment.

The study evaluated 86 patients using a combination of the Exercise for Cancer Patients (EXCAP) program—a low-to-moderate intensity regimen involving walking and resistance training—and low-dose ibuprofen. Researchers found that participants who engaged in the exercise program demonstrated marked improvements in attention compared to those in the placebo group. Furthermore, these patients were less likely to have their cognitive difficulties noticed by friends, family, or colleagues, suggesting a tangible improvement in daily functioning.

While the study also explored the use of low-dose ibuprofen as an anti-inflammatory intervention, the results were less consistent. Although ibuprofen showed some benefits regarding attention, it did not provide the same level of cognitive protection as exercise and even showed mixed results concerning verbal memory. Consequently, researchers emphasize that while exercise appears to be a promising, non-pharmacological strategy for preserving mental sharpness, further large-scale Phase III trials are necessary to fully validate these findings and refine clinical recommendations.

These findings are significant because they offer a low-cost, accessible intervention that patients can integrate into their recovery process. By potentially reducing the severity of cognitive side effects, such programs could help patients maintain their independence and mental well-being while undergoing rigorous cancer therapies.